Dolphin
Senior Member (Voting Rights)
O-Glycosylation patterns in Post-viral Fatigue Syndrome: Sialic Acid-preserving Chemical Release
Daniel García de Otazo Hernándeza,b, Gianluigi Sabatinoa, Eva Untersmayr b, Selina Kepplerc, Davide Reta,b
a Research Unit Macromolecular Chemistry, Institute of Applied Synthetic Chemistry, TU Wien, 1060 Vienna, Austria daniel.garcia@tuwien.ac.at
b Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria c Division of rheumatology and Immunology Medical University of Graz, 8010 Graz, Austria
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex inflammatory condition characterized by chronic fatigue, post-exertional malaise, and immune dysregulation whose underlying mechanisms remain poorly understood. Glycosylation, the process of attaching glycans to proteins and lipids, plays a crucial role in immune cell communication and inflammation [1]. As sialic acid has great importance in autoimmune and inflammatory diseases, the focus was directed towards a controlled release and labelling reaction with all conditions avoiding acidic hydrolysis of sialic acid [Figure 1.].
O-glycan from blood sera and purified antibodies where methyl amidated to stabilize sialic acid [2]. The release reaction proceeds via non-reductive β-elimination and subsequent labelling with a fluorescent compound in conditions able to conserve sialic acid in antennary position. The O-glycan profiles are analyzed by HPLC with fluorescence and MALDI mass spectrometry.
O-glycosylation profiles with intact sialylation of ME/CFS patients and healthy controls reveal an altered O-Glycan pattern which may contribute to the chronic inflammatory state observed in ME/CFS.
Figure 1. Graphical abstract.
O-Glycans from blood serum and antibodies were analyzed from patients and healthy controls using a novel release and labelling method. Image created with BioRender.
References:
1. Rohrhofer, J., et al., Immunological Patient Stratification in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Journal of Clinical Medicine, 2024. 13(1): p. 275.
2. Ret, D., et al., DMTMM-mediated methylamidation for MALDI mass spectrometry analysis of N-glycans with structurally conserved sialic acid residues in biological fluids "via direttissima". Talanta, 2022. 242: p. 123326.
The 22nd European Carbohydrate Symposium, 6-10 July 2025 GDAŃSK, POLAND
Last edited by a moderator: